Becker's Healthcare April 25, 2024
Paige Twenter

Hospital pharmaceutical costs marginally decreased in 2023 because of the lessened need for COVID-19 drugs, but overall healthcare spending on drugs grew 13.5% — largely because of weight loss medications, a new study found.

The researchers said weight loss drugs will continue to increase costs, especially as more are approved and existing ones gain new indications, the American Society of Health-System Pharmacists said in an April 24 news release.

“Adding to the weight loss category, spending on the diabetes drug tizepatide [Mounjaro, Zepbound] grew an astounding 373% even though its approval for weight loss came late in 2023,” the release...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Health System / Hospital, Healthcare System, Patient / Consumer, Pharma, Pharma / Biotech, Pricing / Spending, Provider, Survey / Study, Trends
Why Walgreens Is Reportedly Considering a Private Equity Buyer
Gene Therapy Shows Long-Term Vision Benefits in Rare Eye Disease
Why 2025 Could Be A Good Reimbursement Year For CVS And Walgreens
PBM reform dropped in Congress' funding package
2025 and Beyond: Key Trends to Watch in Pharmacy

Share This Article